# Regeneron Pharmaceuticals, Inc. (REGN): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/regn for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, an injection used to treat various ophthalmic conditions such as wet age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization, diabetic retinopathy, and macular edema resulting from retinal vein occlusion (both central and branch). Other significant offerings are Dupixent, an injectable solution for atopic de...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $805.02 USD |
| Market Cap | $82.88B |
| P/E (TTM) | 17.12 |
| EPS (TTM) | $47.03 |
| 52-Week Range | $575.93 – $859.34 |
| Dividend Yield (TTM) | 0.46% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 0.46% |
| Annual Dividend (TTM) | $3.70 /share |
| Annual Dividend (Forward) | $3.76 /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | — |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | 6.8% / — / — / — |
| Payout Ratio (EPS, TTM) | 9.0% |
| Payout Ratio (FCF, TTM) | 10.7% |
| Payout Ratio (EPS, forward dividend) | 9.3% |
| Payout Ratio (FCF, forward dividend) | 11.0% |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-08-18 | $0.9400 | 2026-08-31 |
| 2026-05-20 | $0.9400 | 2026-06-04 |
| 2026-02-20 | $0.9400 | 2026-03-05 |
| 2025-11-20 | $0.8800 | 2025-12-05 |
| 2025-08-18 | $0.8800 | 2025-09-03 |
| 2025-05-20 | $0.8800 | 2025-06-06 |
| 2025-02-20 | $0.8800 | 2025-03-20 |

Full history: https://www.dividenddata.com/stocks/regn/dividend

## Frequently Asked Questions

### What does Regeneron Pharmaceuticals, Inc. do?

Regeneron Pharmaceuticals, Inc. (REGN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is REGN's market cap?

Regeneron Pharmaceuticals, Inc. (REGN) has a market capitalization of approximately $82.88 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does REGN pay a dividend?

Yes, Regeneron Pharmaceuticals, Inc. (REGN) pays a dividend quarterly, with a trailing-twelve-month yield of 0.46%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### How often does REGN pay dividends?

Regeneron Pharmaceuticals, Inc. pays dividends quarterly. The forward annual rate is $3.76 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is REGN's payout ratio?

Regeneron Pharmaceuticals, Inc.'s payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/regn
- Dividend history & safety: https://www.dividenddata.com/stocks/regn/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/regn/earnings
- Financial statements: https://www.dividenddata.com/stocks/regn/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/regn/valuation
- Peer comparison: https://www.dividenddata.com/stocks/regn/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.